109 related articles for article (PubMed ID: 17710839)
21. Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trial.
Cady RK; Mathew N; Diener HC; Hu P; Haas M; Novak GP;
Headache; 2009 Feb; 49(2):216-26. PubMed ID: 19222595
[TBL] [Abstract][Full Text] [Related]
22. Early vs. non-early intervention in acute migraine-'Act when Mild (AwM)'. A double-blind, placebo-controlled trial of almotriptan.
Goadsby PJ; Zanchin G; Geraud G; de Klippel N; Diaz-Insa S; Gobel H; Cunha L; Ivanoff N; Falques M; Fortea J
Cephalalgia; 2008 Apr; 28(4):383-91. PubMed ID: 18294251
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of rizatriptan for menstrual migraine in an early intervention model: a prospective subgroup analysis of the rizatriptan TAME (Treat A Migraine Early) studies.
Martin V; Cady R; Mauskop A; Seidman LS; Rodgers A; Hustad CM; Ramsey KE; Skobieranda F
Headache; 2008 Feb; 48(2):226-35. PubMed ID: 18005144
[TBL] [Abstract][Full Text] [Related]
24. Randomised, open label, controlled trial of celecoxib in the treatment of acute migraine.
Loo CY; Tan HJ; Teh HS; Raymond AA
Singapore Med J; 2007 Sep; 48(9):834-9. PubMed ID: 17728965
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of an intensive multidisciplinary headache treatment program.
Gunreben-Stempfle B; Griessinger N; Lang E; Muehlhans B; Sittl R; Ulrich K
Headache; 2009 Jul; 49(7):990-1000. PubMed ID: 19473281
[TBL] [Abstract][Full Text] [Related]
26. Headache diagnosis, management and morbidity in the Singapore primary care setting: findings from a general practice survey.
Khu JV; Siow HC; Ho KH
Singapore Med J; 2008 Oct; 49(10):774-9. PubMed ID: 18946609
[TBL] [Abstract][Full Text] [Related]
27. Predictors of migraine headache recurrence: a pooled analysis from the eletriptan database.
Dodick DW; Lipton RB; Goadsby PJ; Tfelt-Hansen P; Ferrari MD; Diener HC; Almas M; Albert KS; Parsons B
Headache; 2008 Feb; 48(2):184-93. PubMed ID: 18234045
[TBL] [Abstract][Full Text] [Related]
28. Migraine and photic stimulation: report on a survey of migraineurs using flickering light therapy.
Noton D
Complement Ther Nurs Midwifery; 2000 Aug; 6(3):138-42. PubMed ID: 11858471
[TBL] [Abstract][Full Text] [Related]
29. Symptoms of migraine in the paediatric population by age group.
Eidlitz-Markus T; Gorali O; Haimi-Cohen Y; Zeharia A
Cephalalgia; 2008 Dec; 28(12):1259-63. PubMed ID: 18727643
[TBL] [Abstract][Full Text] [Related]
30. Impact of oral dexamethasone versus placebo after ED treatment of migraine with phenothiazines on the rate of recurrent headache: a randomised controlled trial.
Kelly AM; Kerr D; Clooney M
Emerg Med J; 2008 Jan; 25(1):26-9. PubMed ID: 18156535
[TBL] [Abstract][Full Text] [Related]
31. Randomized, double-blind, placebo-controlled, proof-of-concept study of the cortical spreading depression inhibiting agent tonabersat in migraine prophylaxis.
Goadsby PJ; Ferrari MD; Csanyi A; Olesen J; Mills JG;
Cephalalgia; 2009 Jul; 29(7):742-50. PubMed ID: 19222510
[TBL] [Abstract][Full Text] [Related]
32. The 'Act when Mild' (AwM) study: a step forward in our understanding of early treatment in acute migraine.
Goadsby PJ
Cephalalgia; 2008 Sep; 28 Suppl 2():36-41. PubMed ID: 18715331
[TBL] [Abstract][Full Text] [Related]
33. Migraine: a review and future directions for treatment.
Linde M
Acta Neurol Scand; 2006 Aug; 114(2):71-83. PubMed ID: 16867028
[TBL] [Abstract][Full Text] [Related]
34. Nebivolol and metoprolol for treating migraine: an advance on beta-blocker treatment?
Schellenberg R; Lichtenthal A; Wöhling H; Graf C; Brixius K
Headache; 2008 Jan; 48(1):118-25. PubMed ID: 18184294
[TBL] [Abstract][Full Text] [Related]
35. Oral metoclopramide as an adjunct to analgesics for the outpatient treatment of acute migraine.
Azzopardi TD; Brooks NA
Ann Pharmacother; 2008 Mar; 42(3):397-402. PubMed ID: 18285561
[TBL] [Abstract][Full Text] [Related]
36. Rapid absorption of sumatriptan powder and effects on glyceryl trinitrate model of headache following intranasal delivery using a novel bi-directional device.
Luthringer R; Djupesland PG; Sheldrake CD; Flint A; Boeijinga P; Danjou P; Demazières A; Hewson G
J Pharm Pharmacol; 2009 Sep; 61(9):1219-28. PubMed ID: 19703372
[TBL] [Abstract][Full Text] [Related]
37. 24-hour distribution of migraine attacks.
Alstadhaug K; Salvesen R; Bekkelund S
Headache; 2008 Jan; 48(1):95-100. PubMed ID: 18184291
[TBL] [Abstract][Full Text] [Related]
38. Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine.
Rahmann A; Wienecke T; Hansen JM; Fahrenkrug J; Olesen J; Ashina M
Cephalalgia; 2008 Mar; 28(3):226-36. PubMed ID: 18254893
[TBL] [Abstract][Full Text] [Related]
39. Correlation of increase in phosphene threshold with reduction of migraine frequency: observation of levetiracetam-treated subjects.
Young W; Shaw J; Bloom M; Gebeline-Myers C
Headache; 2008; 48(10):1490-8. PubMed ID: 19076647
[TBL] [Abstract][Full Text] [Related]
40. Diagnosing and managing migraine headache.
Mueller LL
J Am Osteopath Assoc; 2007 Nov; 107(10 Suppl 6):ES10-6. PubMed ID: 17986672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
